Schizophrenia Research
Volume 122, Issue 1 , Pages 226-231 , September 2010

Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in China

  • John Kasckow

      Affiliations

    • VA Pittsburgh Health Care System MIRECC and Behavioral Health Service; 7180 Highland Dr., Pittsburgh, PA 15206, USA
    • Western Psychiatric Institute and Clinics, University of Pittsburgh Medical Center, 3811 O'Hara St. Pittsburgh, PA 15213, USA
    • Corresponding Author InformationCorresponding author. VA Pittsburgh Health Care System, Behavioral Health, 7180 Highland Dr, Pittsburgh, PA 15206, USA. Tel.: +1 412 954 4344; fax: +1 412 954 5035.
    • ,
  • Nancy Liu

      Affiliations

    • WHO Collaborating Center for Research and Training in Suicide Prevention, Beijing Hui Long Guan Hospital, Beijing, China
    • Department of Psychology, University of Nebraska-Lincoln, Lincoln, Nebraska, USA
    • ,
  • Gretchen L. Haas

      Affiliations

    • VA Pittsburgh Health Care System MIRECC and Behavioral Health Service; 7180 Highland Dr., Pittsburgh, PA 15206, USA
    • Western Psychiatric Institute and Clinics, University of Pittsburgh Medical Center, 3811 O'Hara St. Pittsburgh, PA 15213, USA
    • ,
  • Michael R. Phillips

      Affiliations

    • WHO Collaborating Center for Research and Training in Suicide Prevention, Beijing Hui Long Guan Hospital, Beijing, China
    • Departments of Psychiatry and Epidemiology, Columbia University, New York, USA

Received 28 November 2009 ,Revised 8 February 2010 ,Accepted 15 February 2010.

References 

  1. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B. 1995;57:289–300
  2. Cavanagh JTO, Carson AJ, Sharpe M, Lawrie SM. Psychological autopsy studies of suicide: a systematic review. Psychol. Med. 2003;33:395–405
  3. Conner KR, Duberstein PR, Conwell Y, Seidlitz L, Caine ED. Psychological vulnerability to completed suicide: a review of empirical studies. Suicide Life-Threat. Behav. 2001;31:367–385
  4. Dong JYS, Ho TP, Kan CK. A case-control study of 92 cases of inpatient suicides. J Affect. Disord. 2005;87:91–99
  5. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry. 1978;35:837–844
  6. Fenton WS. Depression, suicide, and suicide prevention in schizophrenia. Suicide Life Threat. Behav. 2000;30:34–49
  7. Freeman GH, Halton JH. Note on an exact treatment of contingency, goodness of fit and other problems of significance. Biometrika. 1951;38:141–149
  8. Gaynes BN, West SL, Ford CA, Frame P, Klein J, Lohr KN. U.S. Preventive Services Task Force. Screening for suicide risk in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2004;140:822–835
  9. Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J. Gen. Intern. Med. 2007;22:1596–1602
  10. Hawton K, Appleby L, Platt S, Foster T, Cooper J, Malmberg A, et al. The psychological autopsy method to study suicide: a review of methodological issues. J. Affect. Disord. 1998;50:269–276
  11. Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br. J. Psychiatry. 2005;187:9–20
  12. Heilä H, Isometsä E, Henriksson , Heikkinen ME, Marttunen MJ, Lönnqvist JK. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am. J. Psychiatry. 1997;154:1235–1242
  13. Isometsa ET. Psychological autopsy studies—a review. Eur. Psychiatry. 2001;16:379–385
  14. Joukamaa M, Heliovaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V. Mental disorders and cause-specific mortality. Br. J. Psychiatry. 2001;179:498–502
  15. Kan CK, Ho TP, Dong JYS, Dunn ELW. Risk factors for suicide in the immediate post-discharge period. Soc. Psychiatry Psychiatr. Epidemiol. 2007;42:208–214
  16. Kleinman A. Social origins of stress and disease: depression, neurasthenia, and pain in modern China. New Haven: Yale University Press; 1986;
  17. Krueger R. The structure of common mental disorders. Arch. Gen. Psychiatry. 1999;56:921–926
  18. Li J, Su JH, Guo YB. A case-control study of suicide among psychiatric inpatients in the Guangzhou Psychiatric Hospital. Chin. Mental Health J. 2008;22:8–10
  19. Meltzer HY, Alphs L, Green AI, Altamura C, Anand R, Bertoldi A, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry. 2003;60:82–91
  20. Montross L, Zisook S, Kasckow JW. Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann. Clin. Psychiatry. 2005;17:173–182
  21. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch. Gen. Psychiatry. 2005;62:247–253
  22. Phillips MR, Yang GH, Zhang YP, Wang L, Ji L, Zhou M. Risk factors for suicide in China: a national case-control psychological autopsy study. Lancet. 2002;360:1728–1736
  23. Phillips MR, Yang GH, Li SR, Li Y. Suicide and the unique prevalence pattern of schizophrenia in mainland China: a retrospective observational study. Lancet. 2004;364:1062–1068
  24. Phillips MR, Shen Q, Liu X, Pritzker S, Streiner D, Conner K, et al. Assessing depressive symptoms in persons who die of suicide in mainland China. J. Affect. Disord. 2007;98:73–82
  25. Ran MS, Chan CL, Xiang MZ, Wu QH. Suicide attempts among patients with psychosis in a Chinese rural community. Acta Psychiatr. Scand. 2003;107:430–435
  26. Ran MS, Wu QH, Conwell Y, Chen EYH, Chan CLW. Suicidal behavior among inpatients with schizophrenia and mood disorders in Chengdu, China. Suicide Life-Threat. Behav. 2004;34:311–319
  27. Ran MS, Xiang MZ, Mao WJ, Hou ZJ, Tang MN, Chen EY, et al. Conwell Y Characteristics of suicide attempts and nonattempters with schizophrenia in a rural community. Suicide Life-Threat. Behav. 2005;35:694–701
  28. Ran MS, Chen EY, Conwell Y, et al. Mortality in people with schizophrenia in rural China. A 10year study. Br. J. Psychiatry. 2007;190:237–242
  29. Rounsaville BJ, Alarcon RD, Andrews G, Jackson JS, Kendell RE, Kendler K. Basic nomenclature issues for DSM–V. In:  Kupfer DJ,  First MB,  Regier DE editor. A research agenda for DSM–V. Washington, DC: American Psychiatric Association; 2002;p. 1–29
  30. Schwartz RC, Cohen BN. Psychosocial correlates of suicidal intent among patients with schizophrenia. Compr. Psychiatry. 2001;42:118–123
  31. Spina E, DeDomenico P, Ruello C, Longobardo N, Gitto C, Ancione M, et al. Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenia. Int. Clin. Psychopharmacol. 1994;9:281–28
  32. Watson D. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. J. Abnorm. Psychol. 2005;114:522–536
  33. Widiger TA, Coker LA. Mental disorders as discrete clinical conditions: Dimensional versus categorical classification. In:  Hersen M,  Turner S editor. Adult psychopathology and diagnosis. 4th ed. New York: Wiley; 2003;p. 3–35
  34. Yang GH, Phillips MR, Zhou MG, Wang LJ, Zhang YP, Xu D. Understanding the unique characteristics of suicide in China: national psychological autopsy study. Biomed. Environ. Sci. 2005;18:379–389
  35. Yim PHW, Yip PSF, Li RHY, Dunn ELW, Yeung WS, Miao YK. Suicide after discharge from psychiatric inpatient care: a case-control study in Hong Kong. Aust. N.Z. J. Psychiatry. 2004;38:65–72
  36. Zhang HS, Xiao SY. Suicide behaviors of inpatients with schizophrenia. Chin. Mental Health J. 2002;16:260–262
  37. Zisook S, McAdams LA, Kuck J, Harris MJ, Bailey A, Patterson TL, et al. Depressive symptoms in schizophrenia. Am. J. Psychiatry. 1999;156:1736–1743
  38. Zisook S, Kasckow J, Golshan S, Fellows I, Solorzano E, Lehman D, et al. Citalopram augmentation for subsyndromal depressive symptoms in middle-aged and older patients with schizophrenia and schizoaffective disorder: a randomized controlled trial. J. Clin. Psychiatry. 2009;70:562–571
  39. Zisook, S., Kasckow, J., Golshan, S., Fellows, I., Lanouette, N., Vahia, I., Mohamed, S., Rao, S., in press. How does augmentation with citalopram affect suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms? J. Clin. Psychiatry.

PII: S0920-9964(10)01142-4

doi: 10.1016/j.schres.2010.02.1056

Schizophrenia Research
Volume 122, Issue 1 , Pages 226-231 , September 2010

Article Tools